These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32819746)

  • 1. New mouthwash: an efficacious intervention for oral ulceration associated with Behçet's disease.
    Senusi A; Kang A; Buchanan JAG; Adesanya A; Aloraini G; Stanford M; Fortune F
    Br J Oral Maxillofac Surg; 2020 Oct; 58(8):1034-1039. PubMed ID: 32819746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of oral health and psycho-social well-being on clinical outcomes in Behçet's disease.
    Senusi A; Higgins S; Fortune F
    Rheumatol Int; 2018 Oct; 38(10):1873-1883. PubMed ID: 30151720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of apremilast for Behçet's syndrome: a real-life single-centre Italian experience.
    De Luca G; Cariddi A; Campochiaro C; Vanni D; Boffini N; Tomelleri A; Cavalli G; Dagna L
    Rheumatology (Oxford); 2020 Jan; 59(1):171-175. PubMed ID: 31280296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trial of Apremilast for Oral Ulcers in Behçet's Syndrome.
    Hatemi G; Mahr A; Ishigatsubo Y; Song YW; Takeno M; Kim D; Melikoğlu M; Cheng S; McCue S; Paris M; Chen M; Yazici Y
    N Engl J Med; 2019 Nov; 381(20):1918-1928. PubMed ID: 31722152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to recognise a Behçet's ulcer from other types of oral ulceration? Defining Behçet's ulceration by an International Delphi Consultation.
    Poveda-Gallego A; Chapple I; Iacucci M; Hamburger J; Murray PI; Rauz S; Wallace GR;
    Clin Exp Rheumatol; 2023 Oct; 41(10):2048-2055. PubMed ID: 37902271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of apremilast for 3 months in Behçet's disease: A prospective observational study.
    Hirahara L; Kirino Y; Soejima Y; Takeno M; Takase-Minegishi K; Yoshimi R; Takeuchi M; Mizuki N; Nakajima H
    Mod Rheumatol; 2021 Jul; 31(4):856-861. PubMed ID: 32996801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genital ulcer severity score and genital health quality of life in Behçet's disease.
    Senusi A; Seoudi N; Bergmeier LA; Fortune F
    Orphanet J Rare Dis; 2015 Sep; 10():117. PubMed ID: 26394620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiling the microbiome of oral and genital mucosal surfaces in Behçet's disease.
    Ogunkolade W; Senusi AA; Desai P; Sacoor S; Bibi A; Gokani B; Sandionigi A; Fortune F
    Clin Immunol; 2023 Aug; 253():109654. PubMed ID: 37257548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of apremilast on genital ulcers, skin lesions, and arthritis in patients with Behçet's disease: A systematic review and meta-analysis.
    Iizuka Y; Takase-Minegishi K; Hirahara L; Kirino Y; Soejima Y; Namkoong HO; Horita N; Yoshimi R; Takeuchi M; Takeno M; Mizuki N; Nakajima H
    Mod Rheumatol; 2022 Oct; 32(6):1153-1162. PubMed ID: 34752620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjunctival ulcers in Behçet's disease.
    Zamir E; Bodaghi B; Tugal-Tutkun I; See RF; Charlotte F; Wang RC; Wechsler B; LeHoang P; Anteby I; Rao NA
    Ophthalmology; 2003 Jun; 110(6):1137-41. PubMed ID: 12799237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of depression, anxiety and fatigue in patients with Behçet's disease.
    Can Sandikci S; Colak S; Omma A; Enecik ME
    Int J Rheum Dis; 2019 Jun; 22(6):974-979. PubMed ID: 30398004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical granulocyte colony-stimulating factor for the treatment of oral and genital ulcers of patients with Behçet's disease.
    Bacanli A; Yerebakan Dicle O; Parmaksizoglu B; Yilmaz E; Alpsoy E
    J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):931-5. PubMed ID: 16922940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Exploration of Some Predictors of Quality of Life-Related to the Innate Immune System, Inflammation, and Disease Activity in Patients with Behcet's Syndrome: An Analytical Cross-sectional Study.
    Faghfouri AH; Shoura SMS; Papi S; Khabbazi A; Baradaran B; Badpeyma M; Faghfuri E
    Curr Rheumatol Rev; 2024; 20(2):200-207. PubMed ID: 37691223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A composite index for determining the impact of oral ulcer activity in Behcet's disease and recurrent aphthous stomatitis.
    Mumcu G; Sur H; Inanc N; Karacayli U; Cimilli H; Sisman N; Ergun T; Direskeneli H
    J Oral Pathol Med; 2009 Nov; 38(10):785-91. PubMed ID: 19614861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral health related quality of life is affected by disease activity in Behçet's disease.
    Mumcu G; Inanc N; Ergun T; Ikiz K; Gunes M; Islek U; Yavuz S; Sur H; Atalay T; Direskeneli H
    Oral Dis; 2006 Mar; 12(2):145-51. PubMed ID: 16476035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of apremilast on quality of life in Behçet's syndrome: analysis of the phase 3 RELIEF study.
    Hatemi G; Mahr A; Takeno M; Kim D; Melikoğlu M; Cheng S; McCue S; Paris M; Chen M; Yazici Y
    RMD Open; 2022 Jul; 8(2):. PubMed ID: 35798511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab for the treatment of resistant oral ulcers in Behçet's disease: a case report and review of the literature.
    Almoznino G; Ben-Chetrit E
    Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S99-102. PubMed ID: 17949561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of apremilast for the treatment of adult patients with oral ulcers associated with Behçet's syndrome.
    Özdede A; Hatemi G
    Expert Opin Pharmacother; 2021 Aug; 22(12):1533-1537. PubMed ID: 34218739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of disease activity on health related quality of life in patients with Behçet's disease: A cross-sectional study.
    Gorial FI; Jabbar MA
    Ann Med Surg (Lond); 2020 Jun; 54():43-46. PubMed ID: 32368339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apremilast for Behçet's syndrome--a phase 2, placebo-controlled study.
    Hatemi G; Melikoglu M; Tunc R; Korkmaz C; Turgut Ozturk B; Mat C; Merkel PA; Calamia KT; Liu Z; Pineda L; Stevens RM; Yazici H; Yazici Y
    N Engl J Med; 2015 Apr; 372(16):1510-8. PubMed ID: 25875256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.